VEGFA and glaucoma: Of note, pre-existing glaucoma and a family history of glaucoma have been reported as risk factors for development of sustained elevations of IOP after anti-VEGF injections.10,11 Ultimately, a more highly powered, longitudinal prospective study that includes glaucoma suspects and those with glaucoma will be needed to fully characterize the relationship between anti-VEGF therapy and aqueous outflow facility in this at risk patient population.